News from CROI 2012

CROI 2012 will bring together over 4000 researchers and doctors whose work is focused on understanding, preventing and treating HIV and AIDS. They will come to Seattle to present research, share findings, discuss and learn.

But what happens in Seattle doesn’t have to stay in Seattle – we want access to the very latest HIV research and developments to be available to anyone who needs it.

NAM’s news writers will be attending the conference and publishing reports here, giving you key information from the studies presented in conference sessions and in the poster hall.

As well as publishing abstracts and posters on the official conference website, the conference organisers film key sessions and produce webcasts, so you can watch presentations and often you can also download slides. We will include relevant links to these in our news stories and bulletins as soon as they become available.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from CROI 2012

Hepatitis C infection now twice as common in HIV+ gay men as injecting drug users, Swiss study finds

Twice as many HIV-positive gay men are now being infected with hepatitis C as HIV-positive injecting drug users, a Swiss study presented to the 19th

Published
06 April 2012
By
Gus Cairns
Serosorting does help prevent HIV – up to a point

A meta-analysis of HIV-negative gay men’s sexual behaviour and HIV incidence rate in four HIV prevention studies, presented earlier this month at the 19th Conference on Retroviruses

Published
19 March 2012
By
Gus Cairns
Treatment as prevention is starting to work in parts of Africa

A longitudinal study from KwaZulu Natal province in South Africa is the first study from the global south to relate an increase in the proportion of adults

Published
18 March 2012
By
Gus Cairns
Thibela TB: Community-wide IPT did not improve TB control in South Africa’s mines at the population level

Giving a six- to nine-month course of isoniazid preventive therapy (IPT) at a ‘community-wide level’ – to everyone working at randomly selected South African gold mines –

Published
15 March 2012
By
Theo Smart
Uncontrolled HIV linked to faster lung function decline

People with detectable HIV viral load and advanced immune deficiency are likely to experience greater decreases in lung function over time, with high viral load linked to

Published
14 March 2012
By
Liz Highleyman
Statins may slightly reduce non-AIDS events and death

Cholesterol-lowering statin drugs showed a trend toward lowering the risk of non-AIDS events and death among people with HIV in a large US cohort, researchers reported last week

Published
14 March 2012
By
Liz Highleyman
Metformin reduces artery plaque in HIV-positive people with metabolic syndrome

The diabetes drug metformin can help stall progression of calcium buildup in the coronary arteries of HIV-positive people with metabolic abnormalities, potentially reducing their risk of cardiovascular events,

Published
14 March 2012
By
Liz Highleyman
Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals

Drug-drug interactions between direct-acting antiviral agents for hepatitis C and some antiretroviral medications used to treat HIV are common, but are often modest and can be managed

Published
14 March 2012
By
Liz Highleyman
Early infant diagnosis for HIV: is it taking place early enough?

Current early infant diagnosis (EID) protocols may need to be revised in the light of current WHO guidelines on the prevention and treatment of HIV-infection in low-resourced

Published
13 March 2012
By
Theo Smart
Elvitegravir Quad pill matches efavirenz and atazanavir combos

The Quad single-tablet regimen, an all-in-one pill containing the experimental integrase inhibitor elvitegravir plus two other antiretroviral drugs and a novel boosting agent, was as effective as

Published
13 March 2012
By
Liz Highleyman
← First123...4Next →

CROI 2012: Les nouvelles

Reportages de NAM depuis la conférence >

Subscribe now

Sign up for our conference email bulletins below